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Acupuncture is a  complementary and 
alternative medical treatment (CAM) 
which is increasingly used in the care 
of cancer patients. Traditionally derived 
from Chinese medicine, nowadays it is 
becoming a  part of evidence-based 
oncology. The use of acupuncture in 
these patients has been recommended 
by the American Cancer Society (ACS) 
for the treatment of side effects associ-
ated with conventional cancer therapy 
and cancer-related ailments. A growing 
body of evidence supports the use of 
acupuncture in the treatment of can-
cer-induced pain and chemothera-
py-related nausea and vomiting. Also 
other indications, such as xerostomia, 
fatigue, hot flashes, anxiety and pe-
ripheral neuropathy, are being con-
stantly evaluated. This article summa-
rizes the most important discoveries 
related to the possible usefulness of 
this method in contemporary oncolo-
gy. Emphasis is placed on the results 
of randomized controlled trials with 
an adequate level of evidence. How-
ever, explanation of the mechanisms 
responsible for these effects requires 
confirmation in further studies with an 
adequate level of evidence. In future, 
acupuncture may become an interest-
ing and valuable addition to conven-
tional medicine.
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Introduction
Complementary and alternative medical treatment (CAM) has gained sig-
nificant interest in recent years [1]. Although the list of CAM has changed 
over the years, the Office of Alternative Medicine (established at the Na-
tional Institutes of Health [NIH] in the USA) nowadays recognizes five major 
categories [2]. Acupuncture, belonging to the Manipulative Therapies cate-
gory, due to its low cost, safety (considering all possible contraindications) 
and the minimal number of side effects is gaining popularity among patients 
[3]. Acupuncture has repeatedly been reported to be useful in oncological 
practice in alleviating side effects of anti-tumor treatment. Numerous clin-
ical trials of acupuncture indicate its potential role in fighting the following 
ailments: nausea and chemotherapy-induced vomiting, pain, xerostomia, 
vasomotor symptoms, neutropenia, fatigue, anxiety, insomnia, lymphoede-
ma after mastectomy, and peripheral neuropathy [4–16]. A sudden increase 
in the number of studies on acupuncture in oncology was first noted in 1997, 
when at the NIH conference a consensus was reached on the use of acu-
puncture, which was then acknowledged as a useful medical procedure [17]. 
This article reviews the literature concerning the referred studies. 
What is acupuncture? 
Acupuncture is a method of treatment that has its origins in Traditional 
Chinese Medicine and is based on over 4,000 years of empirical evidence. 
The technique involves the insertion of thin needles into specific locations 
(energy points) on the patient’s body along energy pathways or meridians. 
According to Chinese philosophy, the hypothetical substance Qi (vital ener-
gy) flows in the human body along the meridians, and blockage of Qi leads 
to a particular ailment [18]. There are 12 main and 8 extra meridians. All the 
main meridians consist of internal channels connected with the 12 body or-
gans and the external channels spreading symmetrically on the skin surface. 
The literature describes around 360 energy points located on the external 
parts of the meridians. Acupuncture is considered to cure diseases by stim-
ulating particular acupoints and removing blockage of Qi [19]. Figures 1–3 
present acupuncture meridian pathways.
Although acupuncture has been studied extensively in both animal and 
human models, little is known about its mechanisms that could explain acu-
puncture’s therapeutic qualities. Table 1 shows suggested mechanisms of 
acupuncture. This treatment method has been the focus of increased inter-
est, which has resulted in a growing number of studies.
Acupuncture as supportive treatment
Chemotherapy agents are considered to be medications with the most 
severe side effects, which in many cases may force the patient to abandon 
therapy. Because of that, proper alleviation of side effects is most crucial. 
Acupuncture should not be seen as a replacement for modern medicines, 
but rather an adjunct with a low level of procedure-related complications 
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that may enhance efficacy and in some cases allow the 
dosage of other drugs to be reduced. Acupuncture as part 
of supportive treatment in oncology has been tested for 
numerous indications. The strongest evidence from a ran-
domized controlled trial (RCT) with low risk of bias sup-
ports the use of acupuncture for control of nausea and 
vomiting related to chemotherapy [25]. This indication 
seems to be very important, as the high emetogenicity 
Table 1. Possible mechanisms of action of acupuncture
Possible mechanisms of action of acupuncture Effects References




•	increasing permeability and dilatation of the 
capillaries
•	promotion of blood flow to the site
•	initiation of the migration of phagocytes and 




•	decreased expression of IL-6, βNGF and TIMP-1
•	reducing proinflammatory cytokines IL-1, IL-6, TNF-a through 
activation of CB2 receptors
•	anti-inflammatory effect 
•	antinociceptive effect on  inflammatory pain
[21, 22]
ANS
•	increasing synchronization between the two branches of the ANS 
and improvement of HRV
•	mediating global physiological regulation
[23]
Stem cells
•	increasing levels of non-differentiated progenitor of stem cells 
CD133+ and CD34– cell  in the serum of patients after spinal cord 
injury
•	promotion of proliferation and differentiation of neural stem cells, 
up-regulation of the growth factors and the expression of VEGF 
mRNA in the rats ischemic brain
•	spinal cord stem cell mobilization
•	protection cerebral injuries after ischemia and 
promotion nerve regeneration
[24]
IL – interleukin; NGF – nerve growth factor; TIMP-1 – tissue inhibitors of metalloproteinase-1; CB2 – cannabinoid receptor 2; ANS – autonomic nervous system;  
HRV – heart rate variability; CD – cluster of differentiation; VEGF – vascular endothelial growth factor
Table 2. Possible mechanisms of action of acupuncture and its effectiveness in the treatment of various types of ailments related to cancer 
therapy
Condition Possible molecular mechanisms of action Clinical trials References






•	influences the endogenous opioid system 
and changes the serotonin transmission
•	has effects on the gastric myoelectrical 
activity
•	increases vagal modulation
•	influences the cerebellar vestibular activities 
RCT:
•	acupuncture significantly reduced the number 
of episodes of emesis between three groups: 
electroacupuncture, minimal needling and 
pharmacotherapy alone (median number of episodes,  
5, 10, and 15, respectively; p < 0.001)
[26]
Cancer pain Opioid peptides
•	increased concentration level observed in the 
serum and brain tissue after acupuncture
Neuromodulation
•	activity modulation of the human brain areas 
(activated in acute or chronic pain) during 
acupuncture in neuroimaging (fMRI, PET, 
EEG)
Meta-analysis of RCTs:
•	acupuncture did not make a better effect than drug 
therapy (n = 886; RR 1.12; 95% CI: 0.98 to 1.28; p = 0.09)
•	combination therapy (acupuncture with drug therapy) 
was more effective than drug therapy alone  (n = 437; 






•	promotes the release of WBC from bone 
marrow
•	prolonging the life of WBC
•	increases the activity of CSFs
•	promotes the proliferation of haemopoietic 
stem cells
•	reduces haemopoietic stem cells damage by 
chemotherapy
•	improves microcirculation
Meta-analysis of RCTs from China: 
•	acupuncture was effective in increasing WBC level
•	mean difference in the WBC level was 1221 WBC/μl  
(95% CI: 636–1807, p < 0.0001)
Pilot study from USA:
Significant increase in the median leukocyte value for 
baseline value after acupuncture (p = 0.046):
•	8600 WBC/μl, 95%  CI: 4800–12000 in the test group
•	4400 WBC/μl, 95%  CI: 2300–10000 in the control group
Decrease in the frequency of occurrence of severe 
leucopoenia (p = 0.02): 
•	30% in the test group
•	90% in the control group
[11, 32–34]




•	increases the opioid peptides level
•	improves blood flow
RCT:
Significant difference between the test group and the 
control group at 6 weeks of treatment was observed in:
•	the mean BPI-SF worst pain scores (on the scale from 
0–10, 10 being the most intense pain; 3.0 vs. 5.5;  
p < 0.001)
•	pain severity (2.6 vs. 4.5; p = 0.003)






•	bilateral activation of the brain function 
area in fMRI that is responsible for salivary 
production
CGRP:
•	increase the release of CGRP, which positively 
affects the salivary flow rates
RCT:
In the acupuncture group as compared to the control 
group was observed:
•	significant reduction  in dry mouth symptoms measured 
by means of the VAS  (p < 0.05) 
•	increase in unstimulated and stimulated salivary flow 
and production (p < 0.001)
[9, 36, 37]
Hot flushes Neuromodulation
•	increases endorphin release and decrease 
noradrenalin and serotonin activity 
in the central nervous system (make 
thermoregulation more stable)
CGRP
•	direct effect on the release of vasodilator – 
CGRP in peripheral nerve endings
RCT:
Significant reduction of hot flushes and sleep 
disturbances was observed in:  
•	16 patients (52%) of the test group
•	7 patients (24%) of the control group. 
•	effect was obtained after the second acupuncture 






•	increases NPY mRNA levels and reduces CRF 
mRNA levels in the amygdala of rats after 
acupuncture
Randomized controlled experimental study:
•	after 10 acupuncture sessions patients with generalized 
anxiety disorders demonstrated significantly reduced 








•	stimulating purinergic signals  (increase 
in the release of adenine nucleotides and 
adenosine from skin keratinocytes) and 
neurotransmission in the central and 
peripheral nervous system
Pilot study: 
•	acupuncture treatment for 6 weeks was effective in 82% 




•	multicomponent Prospective, clinical study:
•	significant improvement after 2 weeks of treatment was 
observed with regard to: general fatigue (p < 0.001), 
physical fatigue (p = 0.016), activity (p = 0.004) and 
motivation (p = 0.024), and lasted for 2 weeks after the 





•	increase the saliva production
•	restore swallowing reflex
•	inhibition the fibrosis process
Case series study:
•	The treatment was effective in: 
9/10 patients (90%) of the test group (subjective 
improvement in the swallowing function, decrease in 
dry mouth symptoms, pain and fatigue level)
•	in 6/7 patients (86%) it was possible to remove the 
PEG tube (a median time of 114 days from the last CRT 
session and acupuncture treatment, the range from 
49 to 368 days)
[42]
Hiccup Modulation of the hiccup reflex arc
•	locally: changing blood perfusion, activating 
the autonomic nervous system, regulating 
inflammatory mediators
•	centrally: influences the hiccup center by 
modulating the secretion of neurotransmitters 
and neurohormones (endogenous opioids, 
norepinephrine, serotonin, substance P)
Case series study:
After 1–3 courses of treatment (over a 1–7-day period) was 
observed:
•	complete symptom relief in 13 patients (81%,  
p < 0.0001); 
•	partial symptom relief in 3 patients (18.8%)
•	substantial improvement in discomfort (p < 0.0001), 
fatigue (p = 0.0078) and anxiety (p < 0.0001)
[43]
Lymphoedema •	unclear Pilot study:
After 4 weeks of treatment, 30% reduction of oedema in 
comparison to the baseline results was observed in 4/9 
patients (44.5%) 
[15]
RCTs – randomized controlled trials; fMRI –  functional magnetic resonance imaging; RR – relative risk; PET – positron emission tomography;  
EEG – electroencephalography; NPY – neuropeptide Y; CRF – corticotropin-releasing factor; CGRP – calcitonin gene-related peptide; VAS – visual analogue score; 
CRT – chemoradiation therapy; PEG – percutaneous endoscopic gastrostomy; AI – aromatase inhibitors; BPI-SF – the Brief Pain Inventory – Short Form;  
WBC – white blood cells; CSFs – colony-stimulating factors 
Table 2. Cont.
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of many cytostatic agents is hard to control even with 
three-drug therapy [26]. Despite many RCTs on treatment 
of other chemotherapy-induced side effects, the level of 
evidence is not yet satisfactory, but considering its relative 
safety, acupuncture may be useful in everyday practice. 
Descriptions of these clinical trials on the effectiveness of 
acupuncture in minimizing cancer treatment-related side 
effects are summarized in Table 2.
Level of evidence issue 
A recently published systemic review stated that other 
indications, such as pain, xerostomia, vasomotor symp-
toms, fatigue, mood disorders, and insomnia, were not 
evaluated in RCTs with an appropriate level of evidence 
[44]. One of the major problems with the reviewed stud-
ies is their poor methodological quality, mostly difficulty 
with blinding and a low number of subjects. Also the opti-
mal design of such studies (acupuncture vs placebo, acu-
puncture vs sham acupuncture) has not been established 
yet [45]. In spite of satisfactory results in most of these 
studies, further research on a larger group of patients is 
necessary. 
Summary
In an oncological setting, acupuncture is still being 
constantly reviewed. Nevertheless, the present available 
evidence suggests that acupuncture may become a safe, 
low-cost and efficient form of complementary therapy in 
modern oncology. The potential role of acupuncture has 
been found in alleviation of various symptoms, but the 
data from the majority of clinical studies on acupuncture 
are heterogeneous. The incomplete description of proce-
dural methodology and insufficient patient groups limit 
their value. Thus, further research on a larger scale on the 
potential use of acupuncture in contemporary oncology is 
required. It should be emphasized that alternative med-
icine may become the source of a number of interesting 
concepts worth examining and testing in research and 
clinical settings.
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